EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Use of human umbilical cord acellular matrix for soft tissue defects in patient with diabetic foot syndrome (case report)

S V Chebotarev, D V Tovpeko, L I Kalyuzhnaya, M E Kotova, A A Kondratenko, D A Volov, V V Khominets, V E Chernov, D A Zemlyanoy, V V Salukhov

Problems of Endocrinology · 07.03.2026 · 72 (1) · 99-107

DOI: 10.14341/probl13615 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Problems of Endocrinology, online erschienen am 07.03.2026. Verfasst von S V Chebotarev und 9 weiteren Autor:innen. Beteiligte Einrichtung: S.M. Kirov Military Medical Academy. Hauptthemen laut MEDLINE: Diabetic Foot, Umbilical Cord, Tissue Engineering. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-healing ulcers pose a serious problem for public health due to the high cost of treatment, prolonged disability of patients, and low efficacy of therapy. They are the leading cause of non-traumatic lower limb amputations. The development of innovative bioengineering products is a significant step in the treatment of non-healing diabetic foot ulcers. One such product is a tissue-engineered acellular product made from highly regenerative human umbilical cord biomaterial. It contains growth factors, cytokines, and components of the extracellular matrix of Wharton’s jelly, which accelerates wound healing. THE AIM of this clinical study is to evaluate the safety and efficacy of a tissue-engineered acellular product from Wharton’s jelly of the umbilical cord for the treatment of chronic non-healing lower limb ulcers in patients with diabetic foot syndrome. RESULTS: a 60-year-old woman diagnosed with type 2 diabetes mellitus had chronic ulcers that had not responded to standard treatment for more than a year and a half. She was observed for 4 weeks in August 2024. As a result of the local application of an acellular product from human umbilical cord, signs of reduction in wound size and their complete healing were noted 4 weeks after the start of observation. CONCLUSION: clinical observation has demonstrated the safety and efficacy of the acellular product from human umbilical cord for the treatment of chronic non-healing ulcers of diabetic origin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootUmbilical CordTissue EngineeringHumansFemaleMiddle AgedWound HealingDiabetes Mellitus, Type 2Wharton Jelly

Autor:innen und Institutionen

  • S.M. Kirov Military Medical Academy.
  • S.M. Kirov Military Medical Academy; Saint Petersburg State Pediatric Medical University.
  • Saint Petersburg State Pediatric Medical University.

Zitieren

APA

Chebotarev, S. V., Tovpeko, D. V., Kalyuzhnaya, L. I., Kotova, M. E., Kondratenko, A. A., Volov, D. A., Khominets, V. V., Chernov, V. E., Zemlyanoy, D. A., & Salukhov, V. V. (2026). Use of human umbilical cord acellular matrix for soft tissue defects in patient with diabetic foot syndrome (case report). Problems of Endocrinology, 72(1), 99-107. https://doi.org/10.14341/probl13615

Vancouver

Chebotarev SV, Tovpeko DV, Kalyuzhnaya LI, Kotova ME, Kondratenko AA, Volov DA, et al. Use of human umbilical cord acellular matrix for soft tissue defects in patient with diabetic foot syndrome (case report). Problems of Endocrinology. 2026;72(1):99-107. doi:10.14341/probl13615

BibTeX
@article{Chebotarev2026,
  author = {Chebotarev, S V and Tovpeko, D V and Kalyuzhnaya, L I and Kotova, M E and Kondratenko, A A and Volov, D A and Khominets, V V and Chernov, V E and Zemlyanoy, D A and Salukhov, V V},
  title = {Use of human umbilical cord acellular matrix for soft tissue defects in patient with diabetic foot syndrome (case report)},
  journal = {Problems of Endocrinology},
  year = {2026},
  volume = {72},
  number = {1},
  pages = {99--107},
  doi = {10.14341/probl13615}
}
Kostenlos starten →